Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 2 (2005), Issue 12 (December)

1. Association study of VDR gene with rheumatoid arthritis in the French population.
   Genes Immun, 6(8): 707-11. [Abstract] [Full-text]
2. Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis.
   Genes Immun, 6(8): 720-2. [Abstract] [Full-text]
3. Synovial fluid macrophages are capable of osteoclast formation and resorption.
   J Pathol, 208(1): 35-43. [Abstract] [Full-text]
4. Immunological consequences of thalidomide treatment in Sjögren's syndrome.
   Ann Rheum Dis, 65(1): 112-4. [Abstract] [Full-text]
5. Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis.
   Ann Rheum Dis, 65(1): 40-4. [Abstract] [Full-text]
6. Growing up and moving on. A multicentre UK audit of the transfer of adolescents with juvenile idiopathic arthritis from paediatric to adult centred care.
   Ann Rheum Dis, 65(1): 74-80. [Abstract] [Full-text]
7. Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology.
   Ann Rheum Dis, 65(1): 45-50. [Abstract] [Full-text]
8. Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?
   Ann Rheum Dis, 65(1): 93-100. [Abstract] [Full-text]
9. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
   Ann Rheum Dis, 65(1): 35-9. [Abstract] [Full-text]
10. Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab.
    Ann Rheum Dis, 65(1): 26-9. [Abstract] [Full-text]
11. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
    Ann Rheum Dis, 65(1): 51-6. [Abstract] [Full-text]
12. Muscle strength, pain, and disease activity explain individual subdimensions of the Health Assessment Questionnaire disability index, especially in women with rheumatoid arthritis.
    Ann Rheum Dis, 65(1): 30-4. [Abstract] [Full-text]
13. Analyzing reliability of change in depression among persons with rheumatoid arthritis.
    Arthritis Rheum, 53(6): 973-8. [Abstract] [Full-text]
14. Preventing work disability among employees with rheumatoid arthritis: what medical professionals can learn from the patients' perspective.
    Arthritis Rheum, 53(6): 965-72. [Abstract] [Full-text]
15. Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set.
    Arthritis Rheum, 53(6): 864-71. [Abstract] [Full-text]
16. Electronically monitored adherence to medications by newly diagnosed patients with juvenile rheumatoid arthritis.
    Arthritis Rheum, 53(6): 905-10. [Abstract] [Full-text]
17. Clinical responsiveness of self-report functional assessment measures for children with juvenile idiopathic arthritis undergoing intraarticular corticosteroid injections.
    Arthritis Rheum, 53(6): 897-904. [Abstract] [Full-text]
18. Use of self-management behaviors to cope with rheumatoid arthritis stressors.
    Arthritis Rheum, 53(6): 939-49. [Abstract] [Full-text]
19. Activity limitation in rheumatoid arthritis correlates with reduced grip force regardless of sex: the Swedish TIRA project.
    Arthritis Rheum, 53(6): 886-96. [Abstract] [Full-text]
20. Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center.
    Arthritis Rheum, 53(6): 872-8. [Abstract] [Full-text]
21. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
    Arthritis Rheum, 53(6): 856-63. [Abstract] [Full-text]
22. Incidence and prevalence of ankylosing spondylitis in Northern Norway.
    Arthritis Rheum, 53(6): 850-5. [Abstract] [Full-text]
23. Longitudinal study of negative workplace events among employed rheumatoid arthritis patients and healthy controls.
    Arthritis Rheum, 53(6): 958-64. [Abstract] [Full-text]
24. A disease-specific self-help program compared with a generalized chronic disease self-help program for arthritis patients.
    Arthritis Rheum, 53(6): 950-7. [Abstract] [Full-text]
25. Patient self-efficacy and health locus of control: relationships with health status and arthritis-related expenditure.
    Rheumatology (Oxford), 45(1): 92-6. [Abstract] [Full-text]
26. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
    Rheumatology (Oxford), 45(1): 106-11. [Abstract] [Full-text]
27. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
    Rheumatology (Oxford), 45(1): 50-2. [Abstract] [Full-text]
28. A simple extension to the Rheumatoid Arthritis Quality of Life Questionnaire (RAQol) to explore individual patient concerns and monitor group outcome in clinical practice.
    Rheumatology (Oxford), 45(1): 61-5. [Abstract] [Full-text]
29. Touch-screen computer systems in the rheumatology clinic offer a reliable and user-friendly means of collecting quality-of-life and outcome data from patients with rheumatoid arthritis.
    Rheumatology (Oxford), 45(1): 66-71. [Abstract] [Full-text]
30. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
    Rheumatology (Oxford), 45(1): 43-9. [Abstract] [Full-text]
31. High positive predictive value of specific antibodies cross-reacting with a 28-kDa Drosophila antigen for diagnosis of ankylosing spondylitis.
    Rheumatology (Oxford), 45(1): 38-42. [Abstract] [Full-text]
32. The spectrum of renal tubular acidosis in paediatric Sjögren syndrome.
    Rheumatology (Oxford), 45(1): 85-91. [Abstract] [Full-text]
33. Fas (CD95)-related apoptosis and rheumatoid arthritis.
    Rheumatology (Oxford), 45(1): 26-30. [Abstract] [Full-text]
34. The pathophysiology of the growth plate in juvenile idiopathic arthritis.
    Rheumatology (Oxford), 45(1): 11-9. [Abstract] [Full-text]
35. Early environmental factors and rheumatoid arthritis.
    Clin Exp Immunol, 143(1): 1-5. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.